Vor Biopharma
VOR
VOR
71 hedge funds and large institutions have $188M invested in Vor Biopharma in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.49% less ownership
Funds ownership: 91.18% → 90.69% (-0.49%)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
42% less capital invested
Capital invested by funds: $326M → $188M (-$138M)
Holders
71
Holding in Top 10
3
Calls
$105K
Puts
$15K
Top Buyers
| 1 | +$5.24M | |
| 2 | +$1.79M | |
| 3 | +$1.26M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$875K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$412K |
Top Sellers
| 1 | -$9.46M | |
| 2 | -$1.75M | |
| 3 | -$1.06M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$808K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$386K |